A novel solid-phase synthetic method for production of N-alkyl-4alkylamino-1-aryl-1H-pyrazolo [3,4-d] pyrimidine-6-carboxamide library

被引:5
作者
Heo, Yun-Jeong [1 ,2 ]
Jeon, Moon-Kook [1 ]
机构
[1] Korea Res Inst Chem Technol, Bio & Drug Discovery Div, 141 Gajeong Ro, Daejeon 305600, South Korea
[2] Korea Univ, Dept Chem, 145 Anam Ro, Seoul 136713, South Korea
关键词
Screening library; Privileged structure; Heterocycle; Pyrazolopyrimidine; Solid-phase organic synthesis; PRIVILEGED STRUCTURE; MEDICINAL CHEMISTRY; DISCOVERY; IDENTIFICATION; SUBSTRUCTURES; DERIVATIVES; DESIGN; POTENT; SELECTIVITY; ANTAGONISTS;
D O I
10.1016/j.tet.2017.08.044
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
This work describes a solid-phase synthetic method for building a compound library of N-alkyl-4alkylamino-1-aryl-1H-pyrazolo[3,4-cl]pyrimidine-6-carboxamide derivatives, that are based on the biologically active 1-aryl-1H-pyrazolo[3,4-d]pyrimidine scaffold. In the first step of this synthetic sequence, condensation reactions of ethyl 5-amino-1-aryl-1H-pyrazole-4-carboxylates with methyl cyanoformate resulted in the formation of esters that underwent hydrolysis to give 1-aryl-4,5-dihydro-1H-pyrazolo [3,4-d]pyrimidin-4-one-6-carboxylic acids. The coupling reaction of these carboxylic acids with primary alkylamine-loaded acid-sensitive methoxybenzaldehyde (AMEBA) resins was followed by amination reactions mediated by benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP). Subsequent cleavage from the solid support resulted in the formation of the target N-alkyl-4alkylamino-1-aryl-1H-pyrazolo[3,4-d]pyrimidine-6-carboxamide derivatives. The reaction conditions for solid-phase transformations were optimized using a solution-phase model study with 2,4dimethoxybenzyl-protected isobutylamine as a reactant in place of the AMEBA resin-loaded isobutylamine. The progress of the solid-phase reactions was monitored by on-bead ATR-FTIR spectroscopy. Diversification experiments were performed by using 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin4-one-6-carboxylic acids and a variety of primary and secondary amine building blocks to build the target compound library. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5959 / 5973
页数:15
相关论文
共 44 条
  • [1] Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives
    Bakr, Rania B.
    Azouz, Amany A.
    Abdellatif, Khaled R. A.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 6 - 12
  • [2] Balkenhohl F, 1996, ANGEW CHEM INT EDIT, V35, P2289
  • [3] Ligand specificity, privileged substructures and protein druggability from fragment-based screening
    Barelier, Sarah
    Krimm, Isabelle
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2011, 15 (04) : 469 - 474
  • [4] Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]
  • [5] 1-phenylpyrazolo[3,4-d]pyrimidines;: Structure-activity relationships for C6 substituents at A1 and A2A adenosine receptors
    Chebib, M
    McKeveney, D
    Quinn, RJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (11) : 2581 - 2590
  • [6] Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A2A receptor antagonists
    Cole, Andrew G.
    Stauffer, Tara M.
    Rokosz, Laura L.
    Metzger, Axel
    Dillard, Lawrence W.
    Zeng, Wenguang
    Henderson, Ian
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 378 - 381
  • [7] Microwave-assisted protocols for the expedited synthesis of pyrazolo[1,5-a] and [3,4-d]pyrimidines
    Daniels, R. Nathan
    Kim, Kwangho
    Lebois, Evan P.
    Muchalski, Hubert
    Hughes, Mary
    Lindsley, Craig W.
    [J]. TETRAHEDRON LETTERS, 2008, 49 (02) : 305 - 310
  • [8] Pyrazolo-pyrimidines:: A novel heterocyclic scaffold for potent and selective p38α inhibitors
    Das, Jagabandhu
    Moquin, Robert V.
    Pitt, Sidney
    Zhang, Rosemary
    Shen, Ding Ren
    McIntyre, Kim W.
    Gillooly, Kathleen
    Doweyko, Arthur M.
    Sack, John S.
    Zhang, Hongjian
    Kiefer, Susan E.
    Kish, Kevin
    McKinnon, Murray
    Barrish, Joel C.
    Dodd, John H.
    Schieven, Gary L.
    Leftheris, Katerina
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) : 2652 - 2657
  • [9] Medicinal Attributes of Imidazo[1,2-a] pyridine Derivatives: An Update
    Devi, Nisha
    Singh, Dharmender
    Rawal, Ravindra K.
    Bariwal, Jitender
    Singh, Virender
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (26) : 2963 - 2994
  • [10] Dolle R.E., 2010, LEAD GENERATION APPR, P259